《丹参川芎嗪配合无创正压通气治疗老年肺心病的临床应用300字》由会员分享，可在线阅读，更多相关《丹参川芎嗪配合无创正压通气治疗老年肺心病的临床应用300字（2页珍藏版）》请在装配图网上搜索。
1、丹参川芎嗪配合无创正压通气治疗老年肺心病的临床应用300字 摘要 目的 探析丹参川芎嗪配合无创正压通气治疗老年肺心病的临床应用效果。方法 从2014年4月2016年4月期间该院收治的老年肺心病患者中随机抽选出118例作为此次研究的研究对象，将所有入选患者平均分成观察组与对照组，每组59例。对照组采用无创正压通气方案进行治疗，观察组采用丹参川芎嗪配合无创正压通气方案进行治疗。观察两组患者的临床指标及心肺功能于治疗前后的变化情况，此外，计算两组的治疗总有效率。 结果 治疗结束后，观察组的各项临床指标明显优于对照组的对应值；观察组的心肺功能改善程度明显大于对照组；观察组的治疗总有效率为93.23%，
2、明显高于对照组的74.58%，组间比较差异有统计学意义（P0.05）。结论 对老年肺心病患者采用丹参川芎嗪配合无创正压通气方案进行治疗，能取得显著疗效，该治疗方案不仅能改善患者的各项临床指标，也能明显提高患者的心肺功能。 毕业关键词 丹参川芎嗪；无创正压通气；老年肺心病；临床应用中图分类号 R541 文献标识码 A 文章编号 1674-0742（2016）07（c）-0007-04Abstract Objective To observe the effect of Salvia miltiorrhiza Ligustrazine Combined with noninvasive posit
3、ive pressure ventilation in the treatment of senile pulmonary heart disease. Methods From April 2014 to 2016 April in our hospital during the period of elderly patients with pulmonary heart disease randomly selected out of 118 cases as the research object of the study， all patients enrolled were div
4、ided into observation group and control group， 59 cases in each group. The control group was treated with noninvasive positive pressure ventilation， and the observation group was treated with Salvia miltiorrhiza Ligustrazine Combined with noninvasive positive pressure ventilation. The clinical index
5、es of the two groups were observed and the changes of cardiac and pulmonary function before and after treatment were observed. In addition， the total effective rate of the two groups was calculated. Results After the end of treatment， the observation group of clinical indicators was significantly be
6、tter than the control group corresponding values； observation group of heart and lung function improvement degree was significantly higher than that of the control group； the total efficiency of treatment in the observation group was 93.33%， significantly higher than that of control group 74.58% of，
7、 data the differences between the two groups has statistical significance （P 0.05）. Conclusion For elderly patients with chronic pulmonary heart disease with Danshen Ligustrazine Combined with noninvasive positive pressure ventilation therapy， can achieve remarkable curative effect， the treatment ca
8、n not only improve the clinical parameters in patients with， can significantly improve the cardiopulmonary function of patients.Key words Salvia miltiorrhiza ligustrazine；Noninvasive positive pressure ventilation；Senile pulmonary heart disease； Clinical application肺心病属于临床常见疾病，于老年群体中具有较高的发病率、致残率以及病死率
9、，其临床症状主要表现为逐步心肺功能不全，病情严重时，还可诱发患者出现呼吸衰竭、心力衰竭等严重并发症，严重影响患者的生活质量与生命安全1-2。相关研究表明，肺心病主要是由于患者支气管、肺动脉及其他部位病变引起，当肺动脉压力上升时，患者体内肺循环受到阻碍作用，进而造成右心肥大3。随着患者病情的蔓延，肺心病也会造成机体中其他器官的不同损伤。目前，临床治疗肺心病时多采用无创正压通气方法，该方法前期治疗效果明显，但由于老年患者多伴有不同程度的心肺衰竭症状，因此，采用无创正压通气治疗老年肺心病的整体疗效不甚满意4-5。该研究随机选择了该院于2014年4月2016年4月期间该院收治的118例老年肺心病患者进行了对照样本试验，旨在观察丹参川芎嗪配合无创正压通气治疗老年肺心病的临床应用效果，现报道如下。
丹参川芎嗪配合无创正压通气治疗老年肺心病的临床应用300字
